Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study locations now total 23, with Murdoch, Western Australia (One Clinical Research Perth) listed. Updated dates and enrollment numbers are shown, and multiple contact details were removed.
    Difference
    5%
    Check dated 2025-12-08T19:28:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 and removes Revision: v3.3.1, indicating a metadata update. No study content, eligibility criteria, or results are changed.
    Difference
    0.0%
    Check dated 2025-12-01T16:32:10.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Additions: a PubMed-based note stating that publications are automatically filled from PubMed, and a new Revision: v3.3.1. Deletions: removal of the older PubMed publication note and Revision: v3.2.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:01:27.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    - The funding-status disclaimer about lapse in government funding has been removed from the page. The study details, contact information, and locations remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:08:54.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Melanoma is added as a topic and a Related Topics link to MedlinePlus Genetics appears on the page.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:43.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page no longer displays related topics linking to Melanoma and MedlinePlus Genetics, which diminishes quick access to related content from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-26T20:23:18.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.